CDK6 and esophageal squamous cell carcinoma: The results showed that there was abnormal amplification of CDK6 in ESCC samples, and the survival period of ESCC patients with high expression of CDK6 was significantly shorter than that of ESCC patients with low expression of CDK6, indicating that CDK6 played an oncogene role in ESCC [42].